Page 12 of 12 – SEC Filing Signatures After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 4/15/2016 Caxton Corporation /s/ Heath N. Weisberg Heath N. Weisberg, as General Counsel and Chief Compliance Officer of Caxton Corporation Date: 4/15/2016 Kovner 2012 Family Trust B /s/ Karen Cross Karen Cross, Vice President and
Treasurer of Cadence Trust Company Date: 4/15/2016 Kovner 2015-A Investment Trust /s/ Karen Cross Karen Cross, Vice President and
Treasurer of Cadence Trust Company Date: 4/15/2016 OB Select Opportunities, LLC By: Caxton Corporation,
Manager of OB Select Opportunities, LLC /s/ Heath N. Weisberg Heath N. Weisberg, as General Counsel and Chief Compliance Officer of Caxton Corporation Date: 4/15/2016 KFO Holdings LLC By: Caxton Corporation, Manager
of KFO Holdings LLC /s/ Heath N. Weisberg Heath N. Weisberg, General Counsel and Chief
Compliance Officer of Caxton Corporation Date: 4/15/2016 Bruce S. Kovner /s/ Heath N. Weisberg Heath N. Weisberg, as attorney
in fact for Bruce Kovner
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. ATTENTION: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001). Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: 4/15/2016 | Caxton Corporation |
| /s/ Heath N. Weisberg | |
| Heath N. Weisberg, as General Counsel and Chief Compliance Officer of Caxton Corporation | |
| Date: 4/15/2016 | Kovner 2012 Family Trust B |
| /s/ Karen Cross | |
| Karen Cross, Vice President and Treasurer of Cadence Trust Company | |
| Date: 4/15/2016 | Kovner 2015-A Investment Trust |
| /s/ Karen Cross | |
| Karen Cross, Vice President and Treasurer of Cadence Trust Company | |
| Date: 4/15/2016 | OB Select Opportunities, LLC |
| By: Caxton Corporation, Manager of OB Select Opportunities, LLC | |
| /s/ Heath N. Weisberg | |
| Heath N. Weisberg, as General Counsel and Chief Compliance Officer of Caxton Corporation | |
| Date: 4/15/2016 | KFO Holdings LLC |
| By: Caxton Corporation, Manager of KFO Holdings LLC | |
| /s/ Heath N. Weisberg | |
| Heath N. Weisberg, General Counsel and Chief Compliance Officer of Caxton Corporation | |
| Date: 4/15/2016 | Bruce S. Kovner |
| /s/ Heath N. Weisberg | |
| Heath N. Weisberg, as attorney in fact for Bruce Kovner |
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
ATTENTION: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
